Vivo Capital’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Hold |
1,114,960
| – | – | 1.09% | 16 |
|
|
2025
Q1 | $11.7M | Hold |
1,114,960
| – | – | 1.54% | 10 |
|
|
2024
Q4 | $26.3M | Hold |
1,114,960
| – | – | 2.94% | 6 |
|
|
2024
Q3 | $40M | Sell |
1,114,960
-520,176
| -32% | -$18.7M | 3.31% | 8 |
|
|
2024
Q2 | $57.7M | Hold |
1,635,136
| – | – | 5.33% | 5 |
|
|
2024
Q1 | $46.4M | Buy |
1,635,136
+600,000
| +58% | +$17M | 3.65% | 8 |
|
|
2023
Q4 | $13.8M | Hold |
1,035,136
| – | – | 1.13% | 17 |
|
|
2023
Q3 | $9.27M | Buy |
1,035,136
+457,494
| +79% | +$4.1M | 1.02% | 25 |
|
|
2023
Q2 | $6.5M | Hold |
577,642
| – | – | 0.45% | 31 |
|
|
2023
Q1 | $6.65M | Hold |
577,642
| – | – | 0.46% | 28 |
|
|
2022
Q4 | $6.7M | Hold |
577,642
| – | – | 0.77% | 28 |
|
|
2022
Q3 | $7.34M | Hold |
577,642
| – | – | 0.81% | 32 |
|
|
2022
Q2 | $3.97M | Hold |
577,642
| – | – | 0.4% | 42 |
|
|
2022
Q1 | $5.57M | Hold |
577,642
| – | – | 0.38% | 42 |
|
|
2021
Q4 | $6.87M | Hold |
577,642
| – | – | 0.41% | 42 |
|
|
2021
Q3 | $9.38M | Hold |
577,642
| – | – | 0.42% | 40 |
|
|
2021
Q2 | $12.2M | Hold |
577,642
| – | – | 0.53% | 35 |
|
|
2021
Q1 | $8.97M | Buy |
577,642
+262,642
| +83% | +$4.08M | 0.32% | 45 |
|
|
2020
Q4 | $6.62M | Hold |
315,000
| – | – | 0.3% | 47 |
|
|
2020
Q3 | $6.36M | Buy |
+315,000
| New | +$6.36M | 0.37% | 48 |
|